Netherlands
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 7.16 B
|
Dec. 31, 2023 | USD 36.38 | 0.42% |
|
Netherlands |
|
2 |
USD 1.15 B
|
Dec. 31, 2023 | USD 27.32 | 1.49% |
|
Netherlands |
|
3 |
USD 688.55 M
|
Dec. 31, 2023 | USD 44.64 | 0.29% |
|
Netherlands |
|
4 |
USD 64.21 M
|
Dec. 31, 2023 | USD 129.11 | 4.28% |
|
Netherlands |
|
5 |
USD 9.88 M
|
Dec. 31, 2023 | USD 8.76 | -0.46% |
|
Netherlands |
|
6 |
USD -26.60 M
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
7 |
USD -40.42 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
8 |
USD -106.90 M
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
|
9 |
USD -154.01 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
10 |
USD -176.86 M
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
11 |
USD -192.28 M
|
Dec. 31, 2023 | USD 667.09 | 1.81% |
|
Netherlands |
|
12 |
USD -253.10 M
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
The Healthcare company in Netherlands with the highest EBITDA is Koninklijke Ahold Delhaize N.V. (Amsterdam Stock Exchange: AD.AS) at USD 7.16 B.
The Healthcare company in Netherlands with the lowest EBITDA is uniQure N.V. (NasdaqGS: QURE) at USD -253.10 M.
The top 10 Healthcare companies in Netherlands by EBITDA are Koninklijke Ahold Delhaize N.V., Koninklijke Philips N.V., Qiagen N.V., Redcare Pharmacy NV, Pharming Group N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V., Pharvaris N.V., Merus N.V. and NewAmsterdam Pharma Company N.V..
The bottom 10 Healthcare companies in Netherlands by EBITDA are uniQure N.V., argenx SE, NewAmsterdam Pharma Company N.V., Merus N.V., Pharvaris N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., Pharming Group N.V., Redcare Pharmacy NV and Qiagen N.V..